Radiolabeled probes for tumor hypoxia imaging

Area of Science:

• Nuclear Medicine
• Radiochemistry
• Oncology

Background:

• Tumor hypoxia drives cancer progression and treatment resistance.
• Non-invasive hypoxia imaging is essential for personalized cancer therapy.

Purpose of the Study:

• To review progress in radiolabeled hypoxia imaging probes.
• To elucidate structure-activity relationships for improved probe design.

Main Methods:

• Focus on bioreductive nitroimidazoles, metal complexes, and hypoxia-induced protein targeting probes.
• Analysis of structural modifications including glycosylation, PEGylation, and positional isomer effects.
• Evaluation of strategies like multivalent approaches, linker optimization, and redox potential tuning.

Main Results:

• Probe development shifted from lipophilic to hydrophilic designs for better pharmacokinetics.
• Specific structural modifications enhance tumor uptake and reduce non-specific signals.
• Fine-tuning redox potential is key for augmenting imaging specificity.

Conclusions:

• Ideal probes require a synergy of appropriate pharmacokinetics, optimal redox potential, and multi-targeting strategies.
• Advanced probe design principles are crucial for the next generation of tumor hypoxia imaging agents.
• This review provides a foundation for developing more effective hypoxia-targeting agents.